CPI
HCT
FUN
CAR-T Cell Therapy
100

What are the due dates for CPI 1?

Jan 1st to April 30th

100

What is the difference between ALLO and AUTO HCT?

ALLO Uses Donor cells

AUTO Uses own cells

100

Whats does CIBMTR stand for?

Centers for International Blood and Marrow Transplant Research

100

What does CAR stand for in CAR-T?

Chimeric Antigen Receptor

200

What is the current percent for overall forms due category?

95%

200

Do all Traditional HCT's get Lymphodepletion therapy?

Yes

Before transplant, you get chemotherapy (chemo) and sometimes radiation to destroy the diseased cells and marrow. Then, the healthy cells are given to you.

200

What is the largest bone in the human body?

The largest bone in the human body is the femur, also known as the thigh bone. 

200

What antigen does CAR-T target?

CD19

which is expressed on the surface of the vast  majority of B cells, including B-cell malignancies.

300

Where can you find CPI guidelines?

CIBMTR Data Management Guide -->

Continuous Process Improvement Program (CPI)

300

What does HLA stand for and what is it?

Human Leukocyte Antigen 

HLA is a protein — or marker — found on most cells in your body


300

How many bones does an adult have in their Body?

206

Fact:Infants are born with approximately 300 bones, but as they grow some of these bones fuse together. 

300

CAR T-cell therapy is associated with serious side  effects, including (3):

Cytokine release syndrome (CRS)

Neurotoxicity

Organ toxicities

400

How many CPI reporting periods are there?

3

400

Where do the healthy cells come from?

Healthy blood-forming cells used in transplant can come from 3 sources:

  • Bone marrow: Spongy tissue inside of bones
  • Peripheral blood stem cells (PBSC): Blood-forming cells from the circulating blood
  • Cord blood: The blood collected from the umbilical cord and placenta after a baby is born
400

How many chromosomes does the average human have?

46 Chromosomes

Or 23 pairs of chromosomes

400

Are CAR-T's genetically modified?

Yes:

CARs are genetically engineered cell surface receptors designed to equip a patient’s own T cells with the ability to recognize and bind to antigens (cell surface proteins) found on tumor cells.